Autobahn Therapeutics

Improving life health for people affected by CNS disorders

Autobahn Therapeutics is a life sciences company in San Diego, United States, founded in 2017. It has raised $208.7M across 3 rounds, most recently a $100.0M Series C in July 2024.

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$208.7M
Last Round
$100.0M Series CJul 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 10 investors for this company. to use credits for reveals, or explore the API.

About

Autobahn Therapeutics is a clinical-stage biotechnology company developing next-generation medications for central nervous system (CNS) disorders, including neuropsychiatric and neuroimmunologic conditions. Its lead candidate ABX-002 is a thyroid hormone receptor beta agonist in Phase 2 trials for bipolar depression, guided by a brain-targeting chemistry platform and biomarker-driven development.

Funding History

Data from Indexed.vcUpdated
Series CSeries CJul 2024
$100.0M

2 more funding events

  • Extension Round20222 investors
  • Series B20206 investors

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×2
  • DevOps ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Life Sciences
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Life Sciences
Series CTotal funding$2.6BNov 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Life Sciences
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Life Sciences
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Autobahn Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/autobahn-therapeutics"><img src="https://indexed.vc/api/badge/company/autobahn-therapeutics" alt="Autobahn Therapeutics on Indexed.vc" width="260" height="76" /></a>